GAMMA Investing
LBRX icon

GAMMA Investing’s LB Pharmaceuticals LBRX Stock Holding History

GAMMA Investing’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.4K Buy
296
+100
+51% +$4.13K ﹤0.01% 3261
2026
Q2 		$6.36K Buy
196
+34
+21% +$999 ﹤0.01% 3381
2026
Q1 		$4K Buy
162
+148
+1,057% +$3.41K ﹤0.01% 3449
2025
Q4 		$312 Buy
+14
New +$245 ﹤0.01% 3961

Other funds holding LBRX

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's LBRX Position: Q3 2026 in Review

GAMMA Investing increased its LB Pharmaceuticals (LBRX) stake by 51% in Q3 2026, buying an estimated $4.13K and bringing the position to 296 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3261.

GAMMA Investing first reported a position in LBRX in Q4 2025 and has held it in 4 quarters since. 5 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • GAMMA Investing held 296 shares of LB Pharmaceuticals worth $11.4K as of Q3 2026.
  • GAMMA Investing bought 100 LB Pharmaceuticals shares in Q3 2026, an estimated $4.13K.
  • LB Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3261 holding.
  • GAMMA Investing first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 5 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.